List of Omniscope osPharma Customers
Dover, 19904, DE,
United States
Since 2010, our global team of researchers has been studying Omniscope osPharma customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Omniscope osPharma for Healthcare ERP from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Omniscope osPharma for Healthcare ERP include: Uz Leuven Belgium, a Belgium based Healthcare organisation with 10000 employees and revenues of $1.00 billion, Agenus, a United States based Life Sciences organisation with 400 employees and revenues of $161.0 million, Bluegene, a United Arab Emirates based Life Sciences organisation with 25 employees and revenues of $2.0 million and many others.
Contact us if you need a completed and verified list of companies using Omniscope osPharma, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Omniscope osPharma customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Agenus | Life Sciences | 400 | $161M | United States | Omniscope | Omniscope osPharma | Healthcare ERP | 2024 | n/a | In 2024 Agenus deployed Omniscope osPharma within its Healthcare ERP footprint to support high-resolution immune profiling tied to the botensilimab plus balstilimab clinical research program. Omniscope collaborated with Agenus to provision osPharma analytics capabilities that underpin immune activation and repertoire analysis workflows used in the program. The deployment emphasized the Omniscope osPharma immune and repertoire analytics modules for clinical research and therapy-response monitoring, as inferred from joint publication and poster authorship listing Omniscope as a partner. Functional workflows implemented include immune profiling data ingestion, repertoire analytics, cohort-level comparative analysis, and visualization tailored for translational research and trial reporting. Operational coverage targeted clinical research and translational science teams supporting the specified oncology program, with the Omniscope osPharma outputs integrated into study-level research workflows and investigational response monitoring. The implementation aligned the Healthcare ERP application with laboratory assay pipelines and study metadata management to create an analytics-driven loop for sample to insight processing. Governance was characterized by close scientific collaboration and joint authorship, with results derived from the Omniscope osPharma implementation presented at ASCO 2025. The presence of Omniscope on the poster and in the joint publication signals operational validation of the Omniscope osPharma configuration within Agenus research workflows. | |
 |
Bluegene | Life Sciences | 25 | $2M | United Arab Emirates | Omniscope | Omniscope osPharma | Healthcare ERP | 2024 | n/a | In 2024, Bluegene formed a partnership with Omniscope to integrate Omniscope osPharma into its clinical and longevity platform. The Omniscope osPharma deployment is embedded within Bluegene's Healthcare ERP footprint to deliver immune sequencing and analytics capabilities for trial readouts and healthspan insights in the United Arab Emirates. Implementation work focused on configuring Omniscope osPharma modules for sequencing data ingestion, immune signature generation, and clinical-readout workflow orchestration. Configuration efforts centered on data pipelines from sequencing outputs to analytics engines, immune signature extraction workflows, and clinical reporting mechanisms to present immune signals to trial teams and longevity product stakeholders. Integration tied Omniscope osPharma to Bluegene's clinical and longevity platform, enabling automated transfer of immune analytics into clinical datasets and downstream analyses. The operational scope covers clinical research, trial operations, and longevity product teams within Bluegene, supporting immune-based endpoints and healthspan insight delivery across projects in the United Arab Emirates. Governance and rollout emphasized sample-to-signal traceability, role based access controls for clinical users, and standardized clinical-readout procedures to ensure consistent use of immune analytics in trials. Rollout was coordinated through the Omniscope partnership, aligning operational workflows and data stewardship practices to the Healthcare ERP context. | |
|
|
Uz Leuven Belgium | Healthcare | 10000 | $1.0B | Belgium | Omniscope | Omniscope osPharma | Healthcare ERP | 2024 | n/a | In 2024 Uz Leuven Belgium implemented Omniscope osPharma to support clinical immune sequencing and longitudinal T cell profiling within its hospital research and clinical analytics environment. Omniscope osPharma was positioned within the institution's Healthcare ERP landscape to provide centralized clinical immune analytics and repertoire tracking capabilities for oncology and translational research programs. The implementation focused on configuring modules for clinical immune analytics and repertoire tracking, with workflows for longitudinal cohort linking, specimen provenance and study-level data curation. Deployment emphasized reproducible analysis pipelines and an analytic workbench for T cell repertoire visualization and reporting, aligned to clinical study protocols and investigator-led research use cases. Operational coverage spanned clinical research, oncology, immunology and pathology teams, with governance oriented to study-level data stewardship, role based access controls and audit trails to support clinical research compliance. The collaboration with Omniscope contributed to a 2025 scientific poster on therapy induced T cell dynamics, reflecting the system's use in immune sequencing and longitudinal T cell profiling in clinical studies. |
Buyer Intent: Companies Evaluating Omniscope osPharma
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||